Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An OK would add an indication for the use of these HIV medications among those switching from stable regimens.
However, the regimen appears much less potent for those who aren’t virally suppressed.
Researchers compared switching to Symtuza with staying on an effective regimen of a boosted protease inhibitor plus Truvada.
Experts emphasize that Truvada for HIV prevention remains highly effective.
According to 48-week data from a recent study, Delstrigo posted good marks against other HIV treatments.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.